Utama › Mieloma Pelbagai
Kajian klinikal Mieloma Pelbagai sedang mengambil peserta di AS
239 kajian untuk Mieloma Pelbagai sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY60 kajian
- Boston, MA42 kajian
- Atlanta, GA41 kajian
- Houston, TX38 kajian
- Durham, NC37 kajian
- Nashville, TN32 kajian
- Denver, CO27 kajian
- Rochester, MN24 kajian
- St. Louis, MO24 kajian
- Columbus, OH24 kajian
- Baldwin Park, CA23 kajian
- Chicago, IL22 kajian
- Seattle, WA22 kajian
- Washington, DC22 kajian
- Edison, NJ22 kajian
- Miami, FL21 kajian
- Salt Lake City, UT21 kajian
- Charlotte, NC21 kajian
- Milwaukee, WI21 kajian
- Queens, NY20 kajian
- Detroit, MI19 kajian
- Jacksonville, FL18 kajian
- Birmingham, AL18 kajian
- Los Angeles, CA17 kajian
- Cincinnati, OH17 kajian
- Dallas, TX17 kajian
- Cleveland, OH16 kajian
- Phoenix, AZ16 kajian
- Philadelphia, PA16 kajian
- Omaha, NE16 kajian
- Tampa, FL15 kajian
- Cedar Rapids, IA15 kajian
- San Francisco, CA15 kajian
- Irvine, CA14 kajian
- Winston-Salem, NC14 kajian
- New Rochelle, NY14 kajian
- New Haven, CT14 kajian
- Clifton, NJ14 kajian
- Portland, OR13 kajian
- Indianapolis, IN13 kajian
Mengikut negeri
- Alabama22 kajian
- Arizona28 kajian
- Arkansas9 kajian
- California70 kajian
- Colorado37 kajian
- Connecticut18 kajian
- Delaware4 kajian
- Florida55 kajian
- Georgia49 kajian
- Idaho3 kajian
- Illinois31 kajian
- Indiana19 kajian
- Iowa17 kajian
- Kansas12 kajian
- Kentucky15 kajian
- Louisiana9 kajian
- Maine3 kajian
- Maryland25 kajian
- Massachusetts44 kajian
- Michigan26 kajian
- Minnesota30 kajian
- Missouri27 kajian
- Montana4 kajian
- Nebraska18 kajian
- New Hampshire4 kajian
- New Jersey38 kajian
- New Mexico5 kajian
- New York75 kajian
- North Carolina52 kajian
- North Dakota5 kajian
- Ohio46 kajian
- Oklahoma3 kajian
- Oregon20 kajian
- Pennsylvania23 kajian
- Rhode Island6 kajian
- South Carolina9 kajian
- South Dakota3 kajian
- Tennessee32 kajian
- Texas53 kajian
- Utah21 kajian
- Virginia20 kajian
- Washington30 kajian
- West Virginia3 kajian
- Wilayah Columbia10 kajian
- Wisconsin28 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06904066A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07582432A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07589634A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Mengambil pesertaFasa 2
Umur 60 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06679829Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06630104Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06948084The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05519085SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07850284A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07409246A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07391657A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05652335A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT04973605Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 120 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT02682667Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Mengambil pesertaFasa 2
Umur 18 hingga 72 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT03412877Tissue Collection for Studies of Lymph Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT01676805A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07518186A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06500884A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07073547A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06768489Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07609940A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07149857A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07258511Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Mengambil pesertaFasa 2
Umur 60 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06052826A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04634552Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.